Publications by authors named "Neil G Almstead"

Claim this Profile
T
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties.
Liangxian Cao, Marla Weetall, Christopher Trotta, Katherine Cintron, Jiyuan Ma, Neil G Almstead

Mol Cancer Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-Negative Bacteria.
Aleksey I Gerasyuto, Michael A Arnold, Jiashi Wang, Guangming Chen, Xiaoyan Zhang, Neil G Almstead

J Med Chem· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria.
Aleksey I Gerasyuto, Michael A Arnold, Jiashi Wang, Guangming Chen, Xiaoyan Zhang, Neil G Almstead

J Med Chem· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Hydroxy-2-pyridones: Discovery and evaluation of a novel class of antibacterial agents targeting DNA synthesis.
Michael A Arnold, Aleksey I Gerasyuto, Jiashi Wang, Wu Du, Yi Jin Kim Gorske, Neil G Almstead

Bioorg Med Chem Lett· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform.
Liangxian Cao, Marla Weetall, Jenelle Bombard, Hongyan Qi, Tamil Arasu, Neil G Almstead

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy.
Matthew G Woll, Hongyan Qi, Anthony Turpoff, Nanjing Zhang, Xiaoyan Zhang, Neil G Almstead

J Med Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy.
Nikolai A Naryshkin, Marla Weetall, Amal Dakka, Jana Narasimhan, Xin Zhao, Neil G Almstead

Science· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein.
Zhengxian Gu, Jason D Graci, Frederick C Lahser, Jamie J Breslin, Stephen P Jung, Neil G Almstead

Antimicrob Agents Chemother· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective synthesis of 1-substituted 4-chloropyrazolo[3,4-d]pyrimidines.
Suresh Babu, Christie Morrill, Neil G Almstead, Young-Choon Moon

Org Lett· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTC124 targets genetic disorders caused by nonsense mutations.
Ellen M Welch, Elisabeth R Barton, Jin Zhuo, Yuki Tomizawa, Westley J Friesen, Neil G Almstead

Nature· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers.
Samit Hirawat, Ellen M Welch, Gary L Elfring, Valerie J Northcutt, Sergey Paushkin, Neil G Almstead

J Clin Pharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis